|
Medicines for Europe can contribute much more to improve healthcare sustainability than described in the OECD “Health at a Glance 2016” report |
Medicines for Europe |
24 Nov 2016 |
Health & Consumers |
|
Medicines for Europe calls for greater cooperation on value added medicines to improve patient-centric innovation |
Medicines for Europe |
22 Nov 2017 |
Health & Consumers |
|
Medicines for Europe announces new President, launches Access to Medicines campaign |
Medicines for Europe |
10 Oct 2017 |
Health & Consumers |
|
Maximising the impact of Biosimilar Medicines requires strategic action in Europe |
Medicines for Europe |
05 Dec 2024 |
Health & Consumers |
|
Market reforms needed to secure essential antibiotics against AMR, report says |
Medicines for Europe |
16 Feb 2023 |
Health & Consumers |
|
Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health |
Medicines for Europe |
16 Jun 2017 |
Health & Consumers |
|
IQVIA Institute Scorecards show biosimilar medicines offer win for patients, policymakers and healthcare systems across Europe |
Medicines for Europe |
30 Jun 2020 |
Health & Consumers |
|
Immediately calls on new President of EU Commission to prioritise Healthcare |
Medicines for Europe |
25 Sep 2019 |
Health & Consumers, InfoSociety |
|
IGBA launches a Biosimilar Medicines Information Campaign |
Medicines for Europe |
01 Feb 2018 |
Health & Consumers |
|
IGBA congratulates the Australian Government for maintaining their Biologics Naming Convention and for strengthening pharmacovigilance |
Medicines for Europe |
29 Jan 2018 |
Health & Consumers |
|
HERA must address outstanding weaknesses in EU pharma framework to be successful |
Medicines for Europe |
16 Sep 2021 |
Health & Consumers |
|
Health at a Glance Report highlights public value of generic, biosimilar and value added medicines |
Medicines for Europe |
26 Nov 2018 |
Health & Consumers |
|
Harmonised bioequivalence guideline paves the way for global generic medicine development and access to medicines |
Medicines for Europe |
26 Apr 2023 |
Health & Consumers |
|
Giving medicines a new life: EU should foster patients’ access to Value Added Medicines |
Medicines for Europe |
30 Nov 2022 |
Health & Consumers |
|
Generic medicines: 70% of dispensed medicines and critical to healthcare |
Medicines for Europe |
10 Apr 2024 |
Health & Consumers |
|
Generic medicine pricing reforms needed in Slovakia to ensure supply for patients |
Medicines for Europe |
23 Jun 2023 |
Health & Consumers |
|
Generic & biosimilar medicines pivotal for safe, effective and affordable access to medicines in Europe |
Medicines for Europe |
28 Nov 2019 |
Health & Consumers |
|
Future of pharmaceutical policy rests on secure supply of essential medicines |
Medicines for Europe |
03 May 2023 |
Health & Consumers |
|
Fulfilling the Biosimilar Promise: Report Highlights Key Principles in Support of a Sustainable Market |
Medicines for Europe |
19 Sep 2016 |
Health & Consumers |
|
Failure to launch: white paper explores the role of inappropriate use of IP in blocking access to generic and biosimilar medicines |
Medicines for Europe |
05 Nov 2020 |
Health & Consumers |
|
Europe’s life science industry urges the UK and EU27 to safeguard patients’ access to medicines with a clear transition period and a future cooperation agreement after Brexit |
Medicines for Europe |
28 Nov 2017 |
Health & Consumers, UK in Europe |
|
European patients need improved access to biosimilar medicines |
Medicines for Europe |
22 Apr 2021 |
Health & Consumers |
|
European Parliament report calls for increased use of off-patent medicines to improve patient access |
Medicines for Europe |
25 Nov 2021 |
Health & Consumers |
|
European Parliament lends its support to a fair cost-based approach on EMA fees |
Medicines for Europe |
30 Jun 2023 |
Health & Consumers |
|
European Organisation for Specialised Nurses (ESNO) launches switch management guide between similar biological medicines - a guide for nurses |
Medicines for Europe |
26 Jun 2018 |
Health & Consumers |
|
European Health Union – first step to greater EU solidarity in health crisis situations |
Medicines for Europe |
11 Nov 2020 |
Health & Consumers |
|
European Commission pilot project on repurposing brings value added innovation to life |
Medicines for Europe |
28 Oct 2021 |
Health & Consumers |
|
European Commission launches: “What I need to know about Biosimilar Medicines - Information for patients”, in 23 EU languages |
Medicines for Europe |
29 Nov 2017 |
Health & Consumers |
|
European Commission Biotech initiative must spearhead next wave of EU biosimilar advances for patients and stimulate manufacturing |
Medicines for Europe |
21 Mar 2024 |
Health & Consumers |
|
EU Semester Country Specific Recommendations: More Efficient Medicine Policies Needed for Patient Access |
Medicines for Europe |
23 May 2017 |
Health & Consumers |
